Evidence map›Paper›PMID 41246677›Full record

ArticleCureus2025

Challenges in Diagnosing Uterine Leiomyosarcoma in Pregnancy: A Case Report and Lessons Learned.

Maryam Fatima, Chameli Subbaraj, Mustafa Guma

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maryam FatimaObstetrics and Gynecology, Basildon University Hospital, Basildon, GBR.
Chameli SubbarajObstetrics and Gynecology, Basildon University Hospital, Basildon, GBR.
Mustafa GumaObstetrics and Gynecology, Basildon University Hospital, Basildon, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uterine leiomyosarcoma (uLMS) is a rare, highly malignant neoplasm arising from the smooth muscle of the uterus and is exceedingly rare in pregnancy. We present a unique case highlighting the risk of misdiagnosis of uLMS as the more common condition of benign degenerating leiomyoma in pregnancy. Our case involves a 35-year-old, primiparous woman, where on a third-trimester scan (30 weeks), a high index of suspicion was raised for uLMS in a pre-existing benign leiomyoma. However, subsequent MRI assessments and multidisciplinary team (MDT) discussions inaccurately attributed it to the degeneration of a fibroid. uLMS was only diagnosed on histopathological examination when she underwent myomectomy for the presumed fibroid eight months postpartum. This caused a significant delay in the definitive surgical management and contributed to substantial iatrogenic upstaging of the disease (i.e., widespread metastasis of parametrial extension, pelvic lymphadenopathy, and pulmonary metastases), ultimately necessitating palliative second-line chemotherapy. Our case report aims to enhance clinicians' understanding of the atypical clinical and radiological features of uLMS with improved detection and management.

Indexed as

degenerating leiomyomamalignant neoplasmmetastasismyomectomyuterine leiomyosarcoma

Identifiers

PMID41246677
PMCPMC12612788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.